By Daniel Gold

Pharmaceutical R&D has contributed to important advances in treating a wide spectrum of diseases and disabilities, but as new drugs are introduced and patent exclusivity ends, the pharmaceutical industry has experienced an unprecedented wave of intellectual property and patent challenges. As the number and complexity of legal suits proliferate, pharmaceutical legal departments are increasingly challenged in containing discovery costs—even though many of these matters involve the same R&D documents related to the compounds.

Read Full Article >>


Phone: 303.824.0900 | Toll Free: 877.557.4273
Fax: 303.293.9073
Privacy Policy | Privacy Shield

About Catalyst

Catalyst designs, builds, hosts and supports the world’s fastest and most powerful e-discovery platform. For 20 years, Catalyst has helped global corporations reduce the total cost of discovery and take control of complex, large-scale discovery and regulatory compliance.

Copyright © 2019 Catalyst Repository Systems. All Rights Reserved.